Percutaneous Tricuspid Valve Treatment Options
- Home
- Percutaneous Tricuspid Valve Treatment Options
Percutaneous Tricuspid Valve Treatment Options
1 – Transcatheter Edge-to-Edge Repair (TEER)
TriClip and PASCAL Systems
These are currently the most commonly performed percutaneous tricuspid interventions.
The concept is similar to the MitraClip procedure.
The valve leaflets are brought closer together using a special device, reducing the opening.
As a result:
- The amount of regurgitant blood decreases
- The valve functions more effectively
What is TriClip?
TriClip is a special clip system used in the treatment of tricuspid regurgitation.
During the procedure:
- Access is gained through the femoral vein in the groin.
- The catheter is advanced into the right heart.
- The clip is guided toward the tricuspid valve.
- The valve leaflets are captured.
- Regurgitation is reduced.
Advantages of TriClip
- Does not require open surgery.
- Hospital stay is short.
- Can provide relief from symptoms.
- Can improve quality of life.
- Particularly suitable for patients at high surgical risk.
What is the PASCAL System?
The PASCAL system is another device that brings the leaflets closer together.
It works similarly to the TriClip, but there are some technical differences in the device structure.
It may offer advantages in certain anatomies.
2 – Tricuspid Valve Annuloplasty Systems
In some patients, the main issue is the enlargement of the valve ring (annulus).
In this case, an attempt is made to restore valve function by reducing the ring size.
Cardioband System
It is one of the most prominent transcatheter annuloplasty systems used today.
During the procedure:
- A special band is placed around the valve.
- The band is tightened in a controlled manner.
- The valve leaflets move closer to each other.
- Regurgitation may decrease.
Advantages
- Considered the catheter version of surgical annuloplasty.
- The natural valve is preserved.
- Does not require open surgery.
3 – Transcatheter Tricuspid Valve Replacement (TTVR)
Placement of a Tricuspid Valve Prosthesis
Repair may not be possible in some patients.
In such cases, next-generation biological valve systems can be used.
In this method:
- A new biological valve is placed in place of the diseased valve.
- Regurgitation can be largely eliminated.
Systems Used Today
- EVOQUE™
- LuX-Valve™
- Cardiovalve™
- Intrepid Tricuspid™
These technologies are developing rapidly and have started to be implemented in many centers.
Who is it Considered For?
- Very advanced tricuspid regurgitation
- Anatomies unsuitable for repair
- High surgical risk
It can be evaluated in such cases.
4 – Heterotopic Valve Implantation (Caval Valve Implantation – CAVI)
Direct intervention on the tricuspid valve may not be possible in some advanced-stage patients.
In this case:
- Into the inferior vena cava (IVC)
- Into the superior vena cava (SVC)
special valves can be placed.
The goal is:
- To reduce back pressure in the venous system
- To reduce edema
- To alleviate the burden on the liver and kidneys.
In Which Patients Is It Used?
- Advanced right heart failure
- Very severe tricuspid regurgitation
- Patients unsuitable for other treatments
Who Can Undergo Tricuspid Valve Interventions?
The following patients may be candidates:
- Advanced tricuspid regurgitation
- Symptoms persisting despite medical therapy
- Signs of right heart failure
- High risk for open surgery
- Patients with significantly impaired quality of life
The decision is always made by a multidisciplinary heart team.
What Tests Are Performed Before the Procedure?
Echocardiography (Echo)
It is the primary evaluation method.
3D Transesophageal Echocardiography (TEE)
Allows a detailed evaluation of valve anatomy.
Cardiac CT
Used for valve measurements and procedural planning.
Right Heart Catheterization
Can help assess pulmonary pressures.
Blood Tests
Liver and kidney functions are evaluated.
Advantages of Percutaneous Tricuspid Interventions
- The breastbone is not opened
- The heart is not stopped
- It is less invasive
- Provides faster recovery
- Can be performed in elderly patients
- Offers an option for high surgical risk patients
- Can improve quality of life
What Are the Potential Risks?
As with any interventional procedure, there are certain risks:
- Bleeding
- Vascular injury
- Cardiac arrhythmias
- Infection
- Stroke
- Pacemaker requirement
- Device displacement
- Rarely, the need for emergency surgery
However, success rates are steadily increasing in experienced centers.
Frequently Asked Questions
Does tricuspid regurgitation completely resolve with medication?
No. Medications can reduce symptoms, but they do not eliminate the structural defect of the valve.
Are tricuspid valve interventions open surgeries?
No. Percutaneous procedures are performed via blood vessels and are not open-heart surgeries.
Which method is most commonly applied?
Today, the most commonly applied methods are edge-to-edge repair (TEER) systems such as TriClip and PASCAL.
Can normal life be resumed after the procedure?
Many patients are able to return to their daily lives within a short time.
Conclusion
Percutaneous tricuspid valve interventions are one of the most significant developments of recent years for patients with advanced tricuspid regurgitation and high surgical risk. Thanks to transcatheter repair systems such as TriClip and PASCAL, annuloplasty methods like Cardioband, next-generation transcatheter valve replacement technologies, and caval valve implantation, effective solutions can be offered to many patients who previously had limited treatment options. With careful patient selection and experienced structural heart teams, these treatments can improve quality of life and reduce symptoms of heart failure.
This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.
Interventional Cardiology Treatments
- TAVI – Transcatheter Aortic Valve Implantation
- Left Atrial Appendage (LAA) Closure
- Percutaneous Tricuspid Valve Treatment Options
- Patent Foramen Ovale (PFO)
- Mitral Balloon Valvuloplasty (PTMC)
- MitraClip / Transcatheter Mitral Valve Repair
- Coronary Angiography
- Carotid Artery Disease
- Carotid Artery Angioplasty and Stenting
- Calcified Vessel Treatment
- Implantable Loop Recorder (ILR)
- Drug-Coated Balloon (DCB) Treatment
- Hypertrophic Cardiomyopathy (HCM)
- Fractional Flow Reserve (FFR / iFR)
- CTO (Chronic Total Occlusion) Treatment
- Atrial Septal Defect (ASD)
- Angioplasty and Stent Placement